EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling

Huynh Van Tin, Lekha Rethi, Satoshi Higa iD, Yu-Hsun Kao iD, Yi-Jen Chen iD

Cells · 2024

DOI: 10.3390/cells13161331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Huynh Van Tin und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Signal Transduction, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Wan Fang Hospital, Foundation for the Development of Internal Medicine in Okinawa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial to viral entry and can cause cardiac injuries. Toll-like receptor 4 (TLR4) and NOD-, LPR-, and pyrin-domain-containing 3 (NLRP3) inflammasome are critical immune system components implicated in cardiac fibrosis. The spike protein activates NLRP3 inflammasome through TLR4 or angiotensin-converting enzyme 2 (ACE2) receptors, damaging various organs. However, the role of spike protein in cardiac fibrosis in humans, as well as its interactions with NLRP3 inflammasomes and TLR4, remain poorly understood.

Methods

We utilized scratch assays, Western blotting, and immunofluorescence to evaluate the migration, fibrosis signaling, mitochondrial calcium levels, reactive oxygen species (ROS) production, and cell morphology of cultured human cardiac fibroblasts (CFs) treated with spike (S1) protein for 24 h with or without an anti-ACE2 neutralizing antibody, a TLR4 blocker, or an NLRP3 inhibitor.

Results

S1 protein enhanced CFs migration and the expressions of collagen 1, α-smooth muscle actin, transforming growth factor β1 (TGF-β1), phosphorylated SMAD2/3, interleukin 1β (IL-1β), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). S1 protein increased ROS production but did not affect mitochondrial calcium content and cell morphology. Treatment with an anti-ACE2 neutralizing antibody attenuated the effects of S1 protein on collagen 1 and TGF-β1 expressions. Moreover, NLRP3 (MCC950) and NF-kB inhibitors, but not the TLR4 inhibitor TAK-242, prevented the S1 protein-enhanced CFs migration and overexpression of collagen 1, TGF-β1, and IL-1β.

Conclusion

S1 protein activates human CFs by priming NLRP3 inflammasomes through NF-κB signaling in an ACE2-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesSignal TransductionSpike Glycoprotein, CoronavirusNF-kappa BFibrosisSARS-CoV-2HumansReactive Oxygen SpeciesFibroblastsToll-Like Receptor 4COVID-19MyocardiumCell MovementCells, CulturedAngiotensin-Converting Enzyme 2

Stichwörter der Autor:innen

NLRP3 inflammasomeangiotensin-converting enzyme 2cardiac fibroblastsspike protein

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesSpike Glycoprotein, CoronavirusNF-kappa Bspike protein, SARS-CoV-2NLRP3 protein, humanReactive Oxygen SpeciesToll-Like Receptor 4Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Orthopedics, Shuangho Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Cardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, Okinawa 901-2131, Japan.
  • Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.

ORCID-Profile: Satoshi Higa, Yu-Hsun Kao, Yi-Jen Chen

Förderung

  • National Science and Technology Council
  • Wan Fang Hospital
  • Foundation for the Development of Internal Medicine in Okinawa

Zitieren

APA

Van Tin, H., Rethi, L., Higa, S., Kao, Y. H., & Chen, Y. J. (2024). Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling. Cells. https://doi.org/10.3390/cells13161331

Vancouver

Van Tin H, Rethi L, Higa S, Kao YH, Chen YJ. Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling. Cells. 2024. doi:10.3390/cells13161331

BibTeX
@article{VanTin2024,
  author = {Van Tin, Huynh and Rethi, Lekha and Higa, Satoshi and Kao, Yu-Hsun and Chen, Yi-Jen},
  title = {Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13161331}
}
Kostenlos starten →